CBRE Group, Inc. announced its appointment as exclusive provider of global real estate services for Novartis International AG, one of the world’s leading pharmaceutical companies.
Under this new mandate, CBRE’s Global Workplace Solutions (GWS) and Advisory & Transaction Services teams will deliver a full suite of real estate and facilities services to the global pharmaceutical company’s 70-million-square-foot (6.5 million square meters) portfolio, which spans more than 90 countries and multiple property types, including office, laboratory, manufacturing and research facilities. CBRE will support Novartis in the transformation of its real estate portfolio, improving its employee workplace experience and driving its sustainability agenda.
Paul Saville-King, President, CBRE Enterprise Accounts, EMEA, said: “CBRE’s ability to provide fully integrated real estate services across the globe makes us the ideal choice for Novartis. We are deeply committed to helping Novartis optimize its real estate portfolio and operating performance worldwide. We also look forward to supporting Novartis as it reduces the environmental impact of its occupancy and transforms its workplace experience, enabling its employees to do their best work for the patients who depend on Novartis every day.”
CBRE was appointed by Novartis following a competitive bidding process. The appointment marks another success for CBRE’s GWS business in the Life Sciences sector, a high-growth area for the company.
Streamlined Integrated Project Delivery Tackles Design Challenges
Encompass Health Rehabilitation Hospital of Central Florida - Sumter County Opens
Rudolph and Sletten Awarded $960M for New UCSF Benioff Children's Hospital
How Designers Create Welcoming Senior Care Communities
Data-Driven Decisions: How Analytics Are Shaping Healthcare Facility Planning